Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Wolfgang Wick"
2
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT00941460
Completed
Phase 2
Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
Essex Pharma GmbH
ClinicalTrials.gov
NCT00941460
Completed
Phase 2
Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive o...
Essex Pharma GmbH
NCT01666600
Terminated
Phase 1/2
NOA-12: BIBF1120 and R-RT in Glioblastoma
Prof. Dr. Wolfgang Wick
ClinicalTrials.gov
NCT01666600
Terminated
Phase 1/2
NOA-12: BIBF1120 and R-RT in Glioblastoma
Prof. Dr. Wolfgang Wick
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease